Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Evodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors.
パッケージサイズ | 在庫状況 | 単価(税別) |
---|---|---|
1 mg | 在庫あり | ¥ 57,500 |
5 mg | 在庫あり | ¥ 144,500 |
10 mg | 在庫あり | ¥ 218,000 |
25 mg | 在庫あり | ¥ 419,500 |
50 mg | 在庫あり | ¥ 564,500 |
100 mg | 在庫あり | ¥ 854,000 |
説明 | Evodenoson (ATL313) is a potent and selective adenosine A2a receptor (A2aR) agonist for the treatment of eye diseases, tumors, and immune system disorders, and may be used in studies of open-angle glaucoma and blood tumors. |
別名 | DE 112, DE-112, ATL 313, DE112, ATL313, ATL-313 |
分子量 | 499.52 |
分子式 | C23H29N7O6 |
CAS No. | 844873-47-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 50 mg/mL (100.1 mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Evodenoson 844873-47-8 GPCR/G Protein Neuroscience Adenosine Receptor DE 112 DE-112 ATL 313 DE112 ATL313 ATL-313 Inhibitor inhibitor inhibit